Pharmaceuticals

The pharmaceutical industry is a EUR 1 trillion sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.
Page 16/16
Category Tools

Pharmaceuticals in Brazil

November 2012 · MarketLine Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00

Pharmaceuticals in Russia

November 2012 · MarketLine Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00

Pharmaceuticals in Norway

November 2012 · MarketLine Pharmaceuticals in Norway industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00

Pharmaceuticals in Taiwan

November 2012 · MarketLine Pharmaceuticals in Taiwan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00

Pharmaceuticals in Poland

November 2012 · MarketLine Pharmaceuticals in Poland industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00

Pharmaceuticals in Canada

November 2012 · MarketLine Pharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00

Pharmaceuticals in Japan

November 2012 · MarketLine Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00

Pharmaceuticals in Germany

November 2012 · MarketLine Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00

Pharmaceuticals in Spain

November 2012 · MarketLine Pharmaceuticals in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00

Pharmaceuticals in Asia-Pacific

November 2012 · MarketLine Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00

Pharmaceuticals in New Zealand

November 2012 · MarketLine Pharmaceuticals in New Zealand industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00

Pharmaceuticals in South Africa

November 2012 · MarketLine Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00

Pharmaceuticals in the Czech Republic

November 2012 · MarketLine Pharmaceuticals in the Czech Republic industry profile provides top-line qualitative and quantitative summary information including: market size (value 2007-11, and forecast to 2016). € 259,00
Options